Company Search:
Advanced Search
Sponsored Links
Nextgen Biomed Ltd Company Snapshot
Nextgen Biomed Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Nextgen Biomed Ltd with three other pharmaceutical manufacturers in Middle East: Hayat Pharmaceutical Industries Company PSC of Jordan (2009 sales of 4.74 million Jordanian Dinars [US$6.69 million] ), Alexandria Pharmaceuticals and Chemical Industries Co of Egypt (209.55 million Egyptian Pounds [US$11.88 million] ), and BioLineRX Ltd. (63.91 million Israel Shekels [US$18.13 million] ).

Sales Analysis.
  Stock Performance Chart for Nextgen Biomed Ltd
  Stock Data: Recent Stock Performance:
  Current Price (9/14/2017): .20
(Figures in Israel Shekels)
1 Week 25.0%   13 Weeks 17.0%  
4 Weeks 20.5%   52 Weeks -27.0%  
Nextgen Biomed Ltd Key Data:
  Ticker: NXGN Country: Israel
  Exchanges: TEL Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2009 Sales 47,859,000
(Year Ending Jan 2010).
Employees: 187
  Currency: Israel Shekels Market Cap: 5,798,835
  Fiscal Yr Ends: December Shares Outstanding: 28,994,177
  Share Type: Closely Held Shares: 14,461,746
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.